Abstract
Various populations of accessory cells differ in their abilities to function as effective antigen-presenting cells (APC) and stimulate CD4+ T cells to produce interleukin-2. Three important factors directly related to APC potency are the expression of class II major histocompatibility complex molecules and the ability to present peptide antigens to the T cell antigen receptor, the expression of costimulatory ligands which deliver important activation signals independent of T cell receptor occupancy and the expression of adhesion molecules which promote conjugate formation so that these activation signals can be effectively delivered to the T cells. The relative importance of these accessory cell functions in T cell activation will be discussed, with an emphasis on costimulation and the CD28/B7 receptor/ligand pair. The consequence of inadequate costimulation by an otherwise effective APC in inducting T cell anergy will also be discussed. *** DIRECT SUPPORT *** A02GS021 00006
Similar content being viewed by others
References
June CH: Signal transduction in T cells. Curr Opin Immunol 1991; 3:287–293.
Klausner RD, Samelson LE: T cell antigen receptor activation pathways: The tyresine kinase connection. Cell 1991;74:875–878.
Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreibe SL: Caltineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991;66:807–815.
Flanagan WM, Corthesy B, Bram RJ, Crabtree GR: Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991;352:803–807.
Umetsu DT, Katzen D, Chatila T, Miller R, Jabara HH, Maher M, Oettgen H, Terhorst C, Geha RS: Requirements for activation of human peripheral blood T cells by mouse monoclonal antibody to CD3. Clin Immunol Immunopathol 1987;43:48–64.
Jenkins MK, Chen C, Jung G, Mueller DL, Schwartz RH: Inibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol 1990;144:16–22.
Nisbet-Brown ER, Lee JWW, Cheung RK, Gelfand EW: Antigen-specific and-nonspecific mitogenic signals in the activation of human T cell clones. J Immunol 1987;138: 3713–3719.
Quill H, Schwartz RH: Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: Specific induction of a long-lived state of proliferative nonre-sponsiveness. J Immunol 1989;138: 3704–3712.
Jenkins MJ, Schwartz RH: Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 1987; 165:302–319.
Jenkins MK, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH; Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T lymphocyte clones. Proc Natl Acad Sci USA 1987;84:5409–5413.
Gaspari AA, Jenkins MK, Katz SI: Class II major histocompatibility complex-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. J Immunol 1988;141:2216–2220.
Bal V, McIndoe A, Denton G, Hudson D, Lombardi G, Lamb J, Lechler R: Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol 1990; 20:1893–1897.
Stadecker MJ, Kamisato JK, Chikunguwo SM: Induction of T helper celi unresponsiveness to antigen by macrophages from schistosomal egg granulomas: A basis for immuno-modulation in schistosomiasis?. J Immunol 1990;145:2697–2700.
Jayaraman S, Luo Y, Dorf ME: Tolerance induction in T helper (Th1) cells by thymic macrophages. J Immunol 1992;148:2672–2681.
Jenkins MK, Mueller D, Schwartz RH, Carding S, Bottomley K, Stadeckor MJ, Urdahl KB, Norton SD: Induction and maintenance of anergy in mature T cells. Adv Exp Med Biol 1991;292:167–176.
Markmann J, Lo D, Naji A, Palmiter RD, Brinster RL, Heber-Katz E: Antigen-presenting function of class II MHC expressing pancreatic beta cells. Nature 1988;336:476–479.
Jenkins MK, Ashwell JD, Schwartz RH: Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen presenting cells. J Immunol 1988; 140:3324–3330.
Jenkins MK, Burrell E, Ashwell JD: Antigen presentation by resting B cells: Effectiveness at inducing T cell proliferation is determined by costimulatory signals, not T cell receptor occupancy. J Immunol 1990;144: 1585–1590.
Mueller DJ, Jenkins MK, Schwartz RH: An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness. J Immunol 1989;142:2617–2628.
Crabree GR: Contingeat genetic regulatory events in T lymphocyte activation. Science 1989;243:355–361.
Jain J, McCaffrey PG, Valge-Archer VE, Rao A: Nuclear factor of activated T cells contains Fos and Jun. Nature 1992;356:801–804.
Go C, Miller J: Differential induction of transcription factors that regulate the interleukin 2 gene during anergy induction and restimulation. J Exp Med 1992;175:1327–1336.
Curran T, Franza BR: Fos and Jun: The AP-1 connection. Cell 1988;55: 395–397.
Rosoff PM, Savage N, Dinarello CA: Interleukin-1 stimulates diacyl-glycerol production in T lymphocytes by a novel mechanism. Cell 1988;54:73–81.
Kang SM, Tran AC, Grill M, Lenard MJ: NF-κB subunit regulation in nontransformed CD4+ T lymphocytes. Science 1992;256:1452–1456.
Junker S, Pedersen S, Schreiber E, Matthias P: Extinction of an immunoglobulin κ promoter in cell hybrids is mediated by the octamer motif and correlates with suppression of Oct-2 expression. Cell 1990; 61:467–474.
Edwards CA, Crabtree GR: Molecular regulation of T lymphocyte activation; in Mond JJ, Cambier JC, Weiss A (eds). Regulation of Cell Growth and Activation. Adv. Regull Cell Growth. New York, Raven Press, 1989, vol. 1 pp 93–118.
Verweij CL, Geerts M, Aarden LA: Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J Biol Chem 1991;266:14179–14182.
Fraser JD, Irving BA, Crabtree GR, Weiss A: Regulation of IL-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991; 25:313–316.
Mueller DL, Jenkins MK, Schwartz RH: Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445–480.
DeSilva DR, Urdahl KB, Jenkins MK: Clonal energy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol 1991;147:3261–3267.
Williams IF, Unanue ER: Costimulatory requirements of murine Th1 clones: The role of accessory cell-derived signals in responses to anti-CD3 antibody. J Immunol 1990; 145:85–93.
Essery G, Feldmann M, Lamb JR: IL-2 can prevent and reverse antigen-induced unresponsiveness in cloned human T lymphocytes. Immunology 1988;64:413–417.
Jenkins MK: The role of cell division in the induction of clonal anergy. Immunol Today 1992;13:69–73.
Goodnow CC, Brink R, Adams E: Breakdown of self-tolerance in anergic B lymphocytes. Nature 1991; 352:532–536.
Williams TM, Moolten D, Burlein J, Romano J, Bhaerman R, Godillot A, Mellon M, Rauscher FJ III, Kant JA: Identification of a zinc finger protein that inhibits IL-2 gene expression. Science 1991;254:1791–1794.
Webb S, Morris C, Sprent J: Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity. Cell 1990;63:1249–1256.
Blackman MA, Gerhard-Burgert H, Woodland DL, Palmer E, Kappler JW, Marrack P: A role for clonal inactivation in T cell tolerance to Mls-1a. Nature 1990;345:540–542.
LaSalle JM, Tolentino PJ, Freeman GJ, Nadler LM, Hafler DA: Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J Exp Med 1992;176: 177–186.
Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ: Model systems for the study of seven-transmembrane-segment receptors. Annu Rev Biochem 1991;60:653–688.
O'Hehir RE, Lamb JR: Induction of specific clonal anergy in human T lymphocytes byStaphylococcus aureus enterotoxins. Proc Natl Acad Sci USA 1990;87:8884–8888.
Weaver CT, Hawrylowicz CM, Unanue ER: T helper cell subsets require the expression of distinct costimulatory signals by APC. Proc Natl Acad Sci USA 1988;85:8181–8185.
Gilbert KM, Hoang KD, Welgle WO: Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol 1990;144:2063–2071.
Vakkila J, Sihvola M, Hurme M: Human peripheral blood-derived dendritic cells do not produce IL-1α, IL-1β, or IL-6. Scand J Immunol 1990;31:335–332.
Springer TA: Adhesion receptors of the immune system. Nature 1990; 346:425–434.
van Seventer GA, Shimizu Y, Shaw S: Roles of multiple accessory molecules in T cell activation. Curr Opin Immunol 1991;3:294–303.
Steinman RM, Young JW: Signals arising from antigen-presenting cells. Curr Opin Immunol 1991;3: 361–372.
Figdor CG, van Kooyk Y, Keizer GD: On the mode of action of LFA-1. Immunol Today 1990;11:277–280.
Altmann DM, Hogg N, Trowsdale J, Wilkinson D: Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells. Nature 1989; 338:512–514.
Kuhlman P, Moy VT, Lollo BA, Brian AA: The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation: Contributions of adhesion and co-activation. J Immunol 1991;146: 1773–1782.
Isobe M, Yagita H, Okumura K, Ihara A: Specific acceptance of cardia allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992;255:1125–1129.
Moingeon P, Chang HC, Wallner BP, Stebbins C, Frey AZ, Reinherz EL: CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature 1989;339: 312–314.
van Seventer GA, Shimizu Y, Horgan KJ, Luce GEG, Webb D, Shaw S: Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: Demonstration with immobilized ligand/monoclonal antibody and implication in monocyte-mediated costimulation. Eur J Immunol 1991; 21:1711–1718.
Liu Y, Janeway CA Jr. Cells that present both specific ligand and co-stimulatory activity are the most efficient inducers of clonal expansion of normal CD4 cells. Proc Natl Acad Sci USA 1992;89:3845–3849.
Moingeon P, Lucich JL, McConkey DJ, Letourneur F, Malissen B, Kochan J, Chang HC, Rodewald HR, Reinherz EL: CD3σ dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells. Proc Natl Acad Sci USA 1992;89: 1492–1496.
Gimmi CD, Freeman GJ, Gribben JG, Sugita K, Freedman AS, Morimoto C, Nadler LM: B cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete IL-2. Proc Natl Acad Sci USA 1991;88:6575–6579.
Jenkins MK, Taylor PS, Norton SD, Urdahl KB: CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 1991;147:2461–2466.
Koulowa L, Clark EA, Shu G, Dupont B: The CD28 ligand B7/BB-1 provides a costimulatory signal for alloactivation of CD4+ T cells. J Exp Med 1991;173:759–762.
Linsley PS, Brady W, Grosmaire LS, Aruffo A, Damle NK, Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and IL-2 mRNA accumulation. J Exp Med 1991;173: 721–730.
Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL: CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med 1992;175:353–360.
Freeman GJ, Gray GS, Gimmi CD, Lombar DB, Zhou LJ, White M, Fingeroth JD, Gribben JG, Nadler LM: Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med 1991;174:625–631.
Reiser H, Freeman GJ, Razi-Wolf Z, Gimmi CD, Benacerraf B, Nadler LM: Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex. Proc Natl Acad Sci USA 1992; 89:271–275.
Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992;356:607–609.
Gross JA, Callas E, Allison JP: Identification and distribution of the costimulatory receptor CD28 in the mouse. J Immunol 1992;149:380–388.
June CH, Ledbetter JA, Linsley PS, Thompson CB: Role of the CD28 receptor in T cell activation. Immunol Today 1990;11:211–216.
Hansen JA, Martin PJ, Nowinski RC: Monoclonal antibodies identifying a novel T cell antigen and Ia antigens of human lymphocytes. Immunogenetics 1980;10:247.
Yokochi T, Holly RD, Clark EA: B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. J Immunol 1982;128:823–827.
Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM: B7, a new member of the immunoglobulin superfamily with unique expression on activated and neoplastic B cells. J Immunol 1989; 143:2714–2722.
Freeman GJ, Freedman AS, Rhynhart K, Nadler LM: γ-Interferon selectively induces B7/BB-1 on monocytes: A possible mechanism for amplification of T cell activation through the CD28 pathway. Blood 1990;76:814A.
Linsley PS, Clark EA, Ledbetter JA: T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 1990;87:5031–5035.
Shaw S, Ginther-Luce GE, Quinones R, Guess RE, Springer TA, Sanders ME: Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones. Nature 1986;323:262–264.
Norton SD, Zuckerman L, Urdall KB, Shefner R, Miller J, Jenkins MK: The CD28 ligand, B7, enhances IL-2 production by providing a costimulatory signal to T cells. J Immunol 1992;149:1556–1561.
Ledbetter JA, Parsons M, Martin PJ, Hansen JA, Rabinovitch PS, June CH: Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: Effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J Immunol 1986;137:3299–3305.
June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB: T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin-2 gene expression. Mol Cell Biol 1987; 7:4472–4481.
Vandenberghe P, Freeman GJ, Nadler LM, Fletcher MC, Kamoun M, Turka LA, Ledbetter JA, Thompson CB, June CH: Antibody and B7/BBI-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cell. J Exp Med 1992;175:951–960.
Lu Y, Granelli-Piperno A, Bjomdahl JM, Phillips CA, Trevillyan JM: CD28-induced T cell activation: Evidence for a protein-tyrosine kinase signal transduction pathway. J Immunol 1992;149:24–29.
Lindsten T, June CH, Ledbetter JA, Stella G, Thompson CB: Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989; 244:339–343.
Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA: CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174:561–569.
Brunet JF, Denzoit F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, Golstein P: A new member of the immunoglobulin superfamily-CTLA-4. Nature 1987;328:267–270.
Liu Y, Jones B, Aruffo A, Sullivan KM, Linsley PS, Janeway CA Jr: Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med 1992;175:437–445.
Bruce J, Symington FW, McKearn TJ, Sprent J: A monoclonal antibody discriminating between subsets of T and B cells. J Immunol 1981;127:2496–2501.
Burkly LC, Lo D, Kanagawa O, Brinster RL, Flavell RA: T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class III-E. Nature 1989;342:564–566.
Ramsdell F, Lantz T, Fowlkes BJ. A nondeletional mechanism of thymic self tolerance. Science 1989;246:1038–1041.
Bonneville M, Ishida I, Mombaerts P, Katsuki M, Verbeek S, Berns A, Tonegawa S: Blockage of αβ T-cell development by TCR γδ transgenes. Nature 1989;342:931–934.
Eynon EE, Parker DC: Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J Exp Med 1992;175:131–138.
Ryan JJ, Gress RE, Hathcock KS, Hodes RJ: Recognition and response to alloantigens in vivo. II. Priming with accessory cell-depleted donor allogeneic splenocytes: Induction of specific unresponsiveness to foreign major histocompatibility complex determinants. J Immunol 1984; 133:2343–2350.
Hori S, Sato S, Kitagawa S, Azuma T, Kokudo S, Hamaoka T, Fujiwara H: Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft. J Immunol 1989;143:1447–1452.
Miller JFAP, Morahan G, Allison J, Hoffmann M: A transgenic approach to the study of peripheral T-cell tolerance. Immunol Rev 1991; 122:103–116.
Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Lecksley RM: Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis: Evidence for expansion of distinct helper T cell subsets. J Exp Med 1986;169:59–62.
Pond L, Wassom DL, Hayes CE: Evidence for differential induction of helper T cell subsets duringTrichinella spiralis infection. J Immunol 1989;143:4232–4237.
Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A: Down-regulation of Th1 cytokine production accompanies induction of Th2 resposes by a parasitic helminth,Schistosoma mansoni. J Exp Med 1991;173:159–166.
Romani L, Mocci S, Bietta C, Lanfaloni L, Puccetti P, Bistoni F: Th1 and Th2 cytokine secretion patterns in murine candidiasis: Association of Th1 responses with acquired resistance. Infect Immun 1991;59: 4647–4654.
Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL: Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 1991;254:277–279.
Gajewski TF, Fitch FW: Anti-proliferative effect of IFN-gamma in murine regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 1988;140:4245–4252.
Fiorentino DF, Bond MW, Mossmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081–2095.
Fiorentino DF, Ziotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3441–3451.
de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915–924.
Ding L, Shevach EM: IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting maerophage costimulatory function. J Immunol 1992;148:3133–3139.
de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209–1220.
Bogdan C, Vodovotz Y, Nathan C: Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549–1555.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnson, J.G., Jenkins, M.K. Accessory cell-derived signals required for T cell activation. Immunol Res 12, 48–64 (1993). https://doi.org/10.1007/BF02918368
Issue Date:
DOI: https://doi.org/10.1007/BF02918368